NewLimit, a startup that aims to increase how long people can live a healthy life by genetically programming their cells, has raised a $130 million Series B led by Kleiner Perkins. New investors Nat Friedman, Daniel Gross, and Khosla Ventures also invested, as did returning backers Founders Fund, Dimension Capital, Elad Gil, Garry Tan, Patrick […]
NewLimit, a startup that aims to increase how long people can live a healthy life by genetically programming their cells, has raised a $130 million Series B led by Kleiner Perkins. New investors Nat Friedman, Daniel Gross, and Khosla Ventures also invested, as did returning backers Founders Fund, Dimension Capital, Elad Gil, Garry Tan, Patrick
During a health-focused event in New York on Tuesday, Google announced that it’s developing a collection of “open” AI models for drug discovery called TxGemma. The AI models, which Google said will be released through its Health AI Developer Foundations program later this month, can understand both “regular text” and the structures of different “therapeutic
Google plans to release new ‘open’ AI models for drug discovery Read More »
Tiny Michigan biotech startup CircNova has raised a $3.3 million seed round for its technology that uses AI to target so-called “circular RNA.” The development holds promise as a new method to quickly develop therapies for conditions that currently have no drug treatments. The new funding is also a victory lap for co-founder and CEO
How automotive exec Crystal Brown founded CircNova, an AI drug discovery biotech Read More »
Aqemia, a French startup that’s meshing “quantum-inspired physics” with machine learning to find new drugs, has raised $38 million in a fresh round of funding led by San Francisco-based VC firm Cathay Innovation. This is Aqemia’s second fundraise of the year — it announced a €30 million ($31.5 million) raise back in January — and
Aqemia raises $38M to find new drugs by meshing theoretical physics with GenAI Read More »
Formation Bio, a startup focused on applying AI to drug development with backing from OpenAI CEO Sam Altman, has raised over a quarter-billion dollars to support its ambitious product roadmap. Formation announced Wednesday that it raised $372 million in a Series D funding round led by Andreessen Horowitz with participation from drug maker Sanofi, Sequoia,
Formation Bio raises $372M to boost drug development with AI Read More »
